Latest Conference Articles

Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics

Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics

September 25th 2020

EASD

A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.

COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics

COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics

September 23rd 2020

EASD

Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.

Study Estimates Average Life Years Lost from Type 1, Type 2 Diabetes

Study Estimates Average Life Years Lost from Type 1, Type 2 Diabetes

September 23rd 2020

EASD

Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.

Diabetics, Both Type 1 and Type 2, at Increased Risk of Falls, Fall-Related Injuries

Diabetics, Both Type 1 and Type 2, at Increased Risk of Falls, Fall-Related Injuries

September 22nd 2020

EASD

A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.

Rheumatoid Arthritis Tied to 23% Increase in Risk of New Diabetes

Rheumatoid Arthritis Tied to 23% Increase in Risk of New Diabetes

September 22nd 2020

EASD

A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.

Diabetes Study Shows Lifestyle Interventions and Metformin Continue to Prevent Type 2 Diabetes After 2 Decades

Diabetes Study Shows Lifestyle Interventions and Metformin Continue to Prevent Type 2 Diabetes After 2 Decades

June 16th 2020

ADA

New data released today from the Diabetes Prevention Program Outcomes Study (DPPOS) shows that in over 2000 patients followed for an average of 22 years, lifestyle programs and treatment with metformin continues to prevent the development of type 2 diabetes in at risk populations.

Research Illuminates Origins of Type 1 Diabetes and Celiac Disease

Research Illuminates Origins of Type 1 Diabetes and Celiac Disease

June 15th 2020

ADA

New data from the Environmental Determinants of Diabetes in the Young (TEDDY) study illuminate the environmental triggers that are thought to cause the autoimmune response leading to type 1 diabetes(T1D) and celiac disease. The data was presented in a symposium at the American Diabetes Association meeting.

Obesity Management: ENDO 2017 Highlights

Obesity Management: ENDO 2017 Highlights

April 6th 2017

ENDO

Could corticosteroid use put your patients at a greater risk of metabolic syndrome?

Endo 2017: Improve Diabetes, Obesity Care

Endo 2017: Improve Diabetes, Obesity Care

April 4th 2017

ENDO

Three studies from ENDO 2017 focused on improving patient care through brain stimulation, an artificial pancreas system, and videoconferencing.

Endo 2017: Men’s Health

Endo 2017: Men’s Health

April 4th 2017

ENDO

Men’s health studies presented at ENDO 2017 included a possible prostate cancer treatment and the potential of hormone therapy to prevent frailty.